The US Food and Drug Administration (FDA) has granted approval to Akeso's differentiated programmed cell death protein 1 ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...

EQS-News: Pentixapharm Holding AG / Key word (s): Conference/Scientific publication Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 ...

A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

Northwestern University spinout Grove Biopharma, a synthetic biology specialist developing a platform known as Bionic ...

Belfast firm to partner with QUB to develop humanised therapeutic antibody to combat treatment-resistant cancers ...

G protein-coupled receptors (GPCRs) are involved in many diseases, yet raising therapeutic antibodies against them is notoriously difficult because the transmembrane receptors contain only short ...

A new study from Karolinska Institutet shows how a small antibody fragment can block fertilization by targeting a key protein ...